Büll U - Search Results

1

[Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin].

Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher MF. Reske SN, et al. Among authors: bull u. Nuklearmedizin. 1996 Apr;35(2):42-52. Nuklearmedizin. 1996. PMID: 8721575 Review. German.

2

[MRI and oncoscintigraphy with 99m-Tc-MIBI in the follow up of thyroid cancer].

Biedermann M, Bares R, Grün B, Dohmen BM, Sabri O, Friedberg C, Büll U. Biedermann M, et al. Among authors: bull u. Nuklearmedizin. 1995 Jun;34(3):87-91. Nuklearmedizin. 1995. PMID: 7630747 German.

3

[Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].

Reske SN, Karstens JH, Henrich MM, Sohn M, Glöckner W, Jakse G, Büll U. Reske SN, et al. Among authors: bull u. Nuklearmedizin. 1993 Jun;32(3):111-9. Nuklearmedizin. 1993. PMID: 8327329 German.

4

[Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].

Bares R, Dohmen BM, Cremerius U, Fass J, Teusch M, Büll U. Bares R, et al. Among authors: bull u. Radiologe. 1996 May;36(5):435-40. doi: 10.1007/s001170050093. Radiologe. 1996. PMID: 8778929 German.

5

[A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding].

Kupferschläger J, Müller B, Schulz G, Kaiser HJ, Wagenknecht G, Bares R, Büll U. Kupferschläger J, et al. Among authors: bull u. Nuklearmedizin. 1997 Mar;36(2):56-64. Nuklearmedizin. 1997. PMID: 9148274 German.

6

[Radioimmunoscintigraphy using SPECT: methodology, problems and clinical experiences].

Bares R, Fass J, Truong S, Büll U, Schumpelick V. Bares R, et al. Among authors: bull u. Nuklearmedizin. 1987 Oct;26(5):202-5. Nuklearmedizin. 1987. PMID: 3501573 German.

7

[An incidental finding of a progressive diaphyseal dysplasia (Camurati-Engelmann syndrome)].

Altehoefer C, Grün B, Bares R, Büll U. Altehoefer C, et al. Among authors: bull u. Nuklearmedizin. 1993 Dec;32(6):325-7. Nuklearmedizin. 1993. PMID: 8295831 German.

8

[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].

Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Büll U. Sabri O, et al. Among authors: bull u. Nuklearmedizin. 1998 May;37(3):83-9. Nuklearmedizin. 1998. PMID: 9604227 German.

9

Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.

Cremerius U, Fabry U, Neuerburg J, Zimny M, Bares R, Osieka R, Büll U. Cremerius U, et al. Among authors: bull u. Nuklearmedizin. 2001 Feb;40(1):23-30. Nuklearmedizin. 2001. PMID: 11373935

10

[The effective half-life of 131I during the treatment of autonomous thyroid disease with radioiodine].

Müller B, Bares R, Büll U. Müller B, et al. Among authors: bull u. Nuklearmedizin. 1991 Jun;30(3):71-6. Nuklearmedizin. 1991. PMID: 1714566 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters